Activity of isatine-sulfadimidine derivatives against 2009 pandemic H1N1 influenza virus in cell culture

Antiviral Chemistry and Chemotherapy

Volumn 20, Issue 3, 2010, Pages 143-146

  Selvam, Periyasamy ^a   Chandramohan, Markandavel ^b   Hurst, Brett L ^c   Smee, Donald F ^c  

^a Devaki Amma Memorial College of Pharmacy   (India)

^b Bharat Ratna Kamarajar Liver Hospital and Research Centre   (India)

^c UTAH STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(1,2 DIHYDRO 2 OXO 3H INDOL 3 YLIDENE)AMINO]N(4,6 DIMETHYL 2 PYRIMIDIN 2YL)BENZENE SULFONAMIDE; ANTIVIRUS AGENT; ISATIN DERIVATIVE; N(4,6 DIMETHYLPYRIMIDIN 2 YL) 4 (2 OXO 1,2 DIHYDRO INDOL 3 YLIDENEAMINO)BENZENE SULFONAMIDE; RIBAVIRIN; SULFADIMIDINE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; INDOLE DERIVATIVE; SPIII 5H; SPIII-5H; SULFONAMIDE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPATHOLOGY; CYTOTOXICITY; DOG; INFLUENZA VIRUS A H1N1; KIDNEY CELL CULTURE; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; CELL LINE; CYTOPATHOGENIC EFFECT; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; INFLUENZA; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; DOGS; HUMANS; INDOLES; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; SULFAMETHAZINE; SULFONAMIDES; VIRUS REPLICATION;

EID: 77649213150     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1471     Document Type: Article

References (17)

1. Flahault A, Vergu E, Boëlle P-Y. Potential for a global dynamic of influenza A (H1N1). BMC Infect Dis 2009; 9:129.
2. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-2615.
3. Krumbholz A, Schmidtke M, Bergmann S, et al. High prevalence of amantadine resistance among circulating European porcine influenza A viruses. J Gen Virol 2009; 90:900-908.
4. Wang SQ, Du QS, Huang RB, et al. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Biochem Biophys Res Commun 2009; 386:432-436.
5. Ellis C, McEwen R. Who should receive Tamiflu for swine flu? BMJ 2009; 339:b2698.
6. Bauer DJ, Sadler PW. The structure-activity relationships of the antiviral chemotherapeutic activity of isatin-bthiosemicarbazone. Br Pharmacol Chemother 1960; 15:101-110.
7. Heiner GG, Fatima N, Russell PK, et al. Field trials of methisazone as a prophylactic agent against smallpox. Am J Epidemiol 1971; 94:435-449.
8. Quenelle DC, Keith KA, Kern ER. In vitro and in vivo evaluation of isatiin-β-thiosemicarbazone and marboran against vaccinia and cowpox virus infections. Antiviral Res 2006; 71:24-30.
9. Sherman L, Edelstein F, Shtacher G, et al. Inhibition of Moloney Leukaemia Virus Production by N-methylisatinβ-4′:4′ diethyl thiosemicarbazone. J Gen Virol 1980; 46:195-203.
10. Teitz Y, Ronen D, Vansover A, et al. Inhibition of human immunodeficiency virus by N-methylisatin-β-4′:4′ diethylthiosemicarbazone and N-allyl isatin-β-4′:4′ diallylthiosemicarbazone. Antiviral Res 1994; 24:305-314.
11. Selvam P, Chandramohan M, De Clercq E, et al. Synthesis and anti-HIV activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6- dimethyl-2-pyrimidinyl)-benzene sulphonamide and its derivatives. Eur J Pharm Sci 2001; 14:313-316.
12. Selvam P, Murugesh N, Chandramohan M, De Clercq E. Pharmacological evaluation of some novel isatin derivatives. Indian J Pharm Sci 2004; 66:465-468.
13. Selvam P, Murugesh N, Chandramohan M, et al. Inhibitory activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6- dimethylpyrimidin-2-yl) benzenesulphonamide and its derivatives against orthopoxvirus replication in vitro. Antivir Chem Chemother 2006; 17:107-110.
14. Selvam P, Murugesh N, Chandramohan M, et al. Antiinfluenza virus activities of 4-[(1,2-dihydro-2-oxo-3Hindol-3-ylidene)amino]-N-(4,6- dimethyl-2-pyrimidin-2-yl) benzenesulphonamide and its derivatives. Antivir Chem Chemother 2006; 17:269-274.
15. Smee DF, Huffman JH, Morrison AC, et al. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities. Antimicrob Agents Chemother 2001; 45:743-748.
16. Reed LJ, Muench M. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27:493-497.
17. Selvam P, Vijayalakshimi P, Smee DF, et al. Novel 3-sulphonamido-quinazolin-4(3H)-one derivatives: microwave-assisted synthesis and evaluation of antiviral activities against respiratory and biodefense viruses. Antivir Chem Chemother 2007; 18:301-305.